|
| Status |
Public on Jun 01, 2005 |
| Title |
EORTC 10994 clinical trial |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
EORTC 10994 is a phase III clinical trial comparing FEC with ET in patients with large operable, locally advanced or inflammatory breast cancer (www.eortc.be). Frozen biopsies were taken at randomisation. RNA was extracted from 100um thickness of 14G core needle biopsies. Adjacent sections were tested by H&E to confirm >20% tumour cell content. 100 ng total RNA per chip were amplified using the Affymetrix small sample protocol (IVT then Enzo). 49 tumours were tested on Affymetrix U133A chips. The CEL files were quantile normalised together using rma. Clinical response data are not available yet.
Keywords = Apocrine carcinoma
Keywords = breast cancer
|
| |
|
| |
|
| Contributor(s) |
Iggo RD |
| Citation(s) |
15897907 |
| |
| Submission date |
Jul 14, 2004 |
| Last update date |
Aug 10, 2018 |
| Contact name |
Richard Iggo |
| E-mail(s) |
[email protected]
|
| Phone |
+33 5 56 33 04 23
|
| Fax |
+33 5 56 33 32 06
|
| Organization name |
University of Bordeaux
|
| Department |
Bergonie Cancer Institute
|
| Lab |
INSERM U916
|
| Street address |
229 cours de l'Argonne
|
| City |
Bordeaux |
| ZIP/Postal code |
33076 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL96 |
[HG-U133A] Affymetrix Human Genome U133A Array |
|
| Samples (49)
|
|
| Relations |
| BioProject |
PRJNA90875 |
Less...
More...